TY - JOUR
T1 - Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis
AU - Gilles, Laure
AU - Arslan, Ahmet Dirim
AU - Marinaccio, Christian
AU - Wen, Qiang Jeremy
AU - Arya, Priyanka
AU - McNulty, Maureen
AU - Yang, Qiong
AU - Zhao, Jonathan C.
AU - Konstantinoff, Katerina
AU - Lasho, Terra
AU - Pardanani, Animesh
AU - Stein, Brady
AU - Plo, Isabelle
AU - Sundaravel, Sriram
AU - Wickrema, Amittha
AU - Migliaccio, Annarita
AU - Gurbuxani, Sandeep
AU - Vainchenker, William
AU - Platanias, Leonidas C.
AU - Tefferi, Ayalew
AU - Crispino, John D.
N1 - Funding Information:
Acknowledgments This work was supported by NIH grants R01HL112792 (to JDC); PO1 CA108671 (to AM); R01CA77816 and R01CA155566 (to LCP); and by the Samuel Waxman Cancer Research Foundation (to JDC). ADA was supported by NIH training grant T32CA070085. MM was supported by NIH training grant T32CA009560.
PY - 2017/4/3
Y1 - 2017/4/3
N2 - Primary myelofibrosis (PMF) is a clonal hematologic malignancy characterized by BM fibrosis, extramedullary hematopoiesis, circulating CD34+ cells, splenomegaly, and a propensity to evolve to acute myeloid leukemia. Moreover, the spleen and BM of patients harbor atypical, clustered megakaryocytes, which contribute to the disease by secreting profibrotic cytokines. Here, we have revealed that megakaryocytes in PMF show impaired maturation that is associated with reduced GATA1 protein. In investigating the cause of GATA1 downregulation, our gene-expression study revealed the presence of the RPS14-deficient gene signature, which is associated with defective ribosomal protein function and linked to the erythroid lineage in 5q deletion myelodysplastic syndrome. Surprisingly, reduced GATA1 expression and impaired differentiation were limited to megakaryocytes, consistent with a proproliferative effect of a GATA1 deficiency on this lineage. Importantly, expression of GATA1 effectively rescued maturation of PMF megakaryocytes. Together, these results suggest that ribosomal deficiency contributes to impaired megakaryopoiesis in myeloproliferative neoplasms.
AB - Primary myelofibrosis (PMF) is a clonal hematologic malignancy characterized by BM fibrosis, extramedullary hematopoiesis, circulating CD34+ cells, splenomegaly, and a propensity to evolve to acute myeloid leukemia. Moreover, the spleen and BM of patients harbor atypical, clustered megakaryocytes, which contribute to the disease by secreting profibrotic cytokines. Here, we have revealed that megakaryocytes in PMF show impaired maturation that is associated with reduced GATA1 protein. In investigating the cause of GATA1 downregulation, our gene-expression study revealed the presence of the RPS14-deficient gene signature, which is associated with defective ribosomal protein function and linked to the erythroid lineage in 5q deletion myelodysplastic syndrome. Surprisingly, reduced GATA1 expression and impaired differentiation were limited to megakaryocytes, consistent with a proproliferative effect of a GATA1 deficiency on this lineage. Importantly, expression of GATA1 effectively rescued maturation of PMF megakaryocytes. Together, these results suggest that ribosomal deficiency contributes to impaired megakaryopoiesis in myeloproliferative neoplasms.
UR - http://www.scopus.com/inward/record.url?scp=85018710687&partnerID=8YFLogxK
U2 - 10.1172/JCI82905
DO - 10.1172/JCI82905
M3 - Article
C2 - 28240607
AN - SCOPUS:85018710687
SN - 0021-9738
VL - 127
SP - 1316
EP - 1320
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 4
ER -